Bryan Johnson, a tech entrepreneur, has stopped using rapamycin, a drug not approved for anti-aging by the FDA, following concerns it may have aged him and caused infections. Johnson experienced ...

Ertz was listed as a limited participant in Wednesday's practice due to a rib injury. On Washington's initial divisional-round injury report released Tuesday, Ertz was listed as a non-participant ...

Brianna LaPaglia is finding sunnier skies. Three months after Zach Bryan announced the end of their year-long relationship, the TikToker—who is also known as Brianna “Chickenfry” on social ...

The Diontae Johnson experiment is over in Houston. The Texans announced Tuesday they had waived the former Pro Bowl wideout ahead of their divisional-round matchup vs. the Kansas City Chiefs.

Commissions do not affect our editors' opinions or evaluations. Cerner is no longer available to new applicants. Cerner is now Oracle Health, please see the product’s website for more information.

Among those names are Tampa Bay Buccaneers offensive coordinator Liam Coen and Detroit Lions offensive coordinator Ben Johnson, two coaches who entered the process as potential favorites for ...

Diontae Johnson has been claimed on waivers by the Baltimore Ravens one day after he parted ways with the Houston Texans, according to ESPN's Adam Schefter. Johnson joined the Texans on Dec. 26 ...

Diontae Johnson's 2024 odyssey has reached another twist. The Texans waived Johnson on Tuesday, the team announced. "With Diontae, unfortunately it didn't work out and we're on to the Chiefs ...

A group led by Edmonton Oilers forward Zach Hyman and his family have purchased the Ontario Hockey League’s Brantford Bulldogs. The league announced Monday that its board of governors has ...

Zach LaVine is arguably playing the best basketball of his career right now. In six straight games for the Chicago Bulls, he has scored more than 30 points while making 50% or more of his field ...

The purchase will allow Johnson & Johnson to delve further into the treatment of central nervous system disorders. The purchase is one of several transactions in recent years to boost its ...

Johnson & Johnson (NYSE:JNJ) announced a $14.6 billion acquisition of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) ahead of this week’s JP Morgan Healthcare Conference. Shares of Intra-Cellular ...